{"id":47261,"date":"2022-08-12T19:01:59","date_gmt":"2022-08-12T17:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"modified":"2022-08-12T19:01:59","modified_gmt":"2022-08-12T17:01:59","slug":"erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","title":{"rendered":"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM &#8211; United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5525732\/erosive-esophagitis-epidemiology-forecast-2032?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=k79dxh&amp;utm_campaign=1738125+-+Erosive+Esophagitis+Epidemiology+Forecasts%2C+2032%3A+Focus+on+7MM+-+United+States%2C+Germany%2C+Spain%2C+Italy%2C+France%2C+United+Kingdom%2C+and+Japan&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Erosive Esophagitis &#8211; Epidemiology Forecast &#8211; 2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Erosive Esophagitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/p>\n<p>\n<strong>Erosive Esophagitis Epidemiology Perspective<\/strong>\n<\/p>\n<p>\nThe Erosive Esophagitis epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Erosive Esophagitis epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.\n<\/p>\n<p>\nThe Erosive Esophagitis epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.\n<\/p>\n<p>\n<strong>Erosive Esophagitis Detailed Epidemiology Segmentation<\/strong>\n<\/p>\n<p>\nThe Erosive Esophagitis epidemiology covered in the report provides historical as well as forecasted Erosive Esophagitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.\n<\/p>\n<p>\nThe Erosive Esophagitis report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.\n<\/p>\n<p>\n<strong>KOL views<\/strong>\n<\/p>\n<p>\nThe publisher interviews, KOLs and SME&#8217;s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.\n<\/p>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe Erosive Esophagitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns\n<\/li>\n<li>\nThe Erosive Esophagitis Epidemiology Report and Model provide an overview of the global trends of Erosive Esophagitis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)\n<\/li>\n<li>\nThe report provides insight into the historical and forecasted patient pool of Erosive Esophagitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan\n<\/li>\n<li>\nThe report helps recognize the growth opportunities in the 7MM for the patient population\n<\/li>\n<li>\nThe report assesses the disease risk and burden and highlights the unmet needs of Erosive Esophagitis\n<\/li>\n<li>\nThe report provides the segmentation of the Erosive Esophagitis epidemiology\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\n11-year Forecast of Erosive Esophagitis epidemiology\n<\/li>\n<li>\n7MM Coverage\n<\/li>\n<li>\nPrevalent and Diagnosed Cases of Erosive Esophagitis\n<\/li>\n<li>\nCases of Erosive Esophagitis by Mutation Types\n<\/li>\n<li>\nErosive Esophagitis Cases associated with Clinical Manifestations\n<\/li>\n<\/ul>\n<p>\n<strong>Key Assessments<\/strong>\n<\/p>\n<ul>\n<li>\nPatient Segmentation\n<\/li>\n<li>\nDisease Risk &amp; Burden\n<\/li>\n<li>\nRisk of disease by the segmentation\n<\/li>\n<li>\nFactors driving growth in a specific patient population\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Key Insights<\/strong>\n<\/p>\n<p>\n<strong>2. Executive Summary of Erosive Esophagitis<\/strong>\n<\/p>\n<p>\n<strong>3. Erosive Esophagitis: Disease Background and Overview<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Sign and Symptoms\n<\/p>\n<p>\n3.3. Pathophysiology\n<\/p>\n<p>\n3.4. Risk Factors\n<\/p>\n<p>\n3.5. Diagnosis\n<\/p>\n<p>\n<strong>4. Patient Journey<\/strong>\n<\/p>\n<p>\n<strong>5. Epidemiology and Patient Population<\/strong>\n<\/p>\n<p>\n5.1. Epidemiology Key Findings\n<\/p>\n<p>\n5.2. Assumptions and Rationale: 7MM\n<\/p>\n<p>\n5.3. Epidemiology Scenario: 7MM\n<\/p>\n<p>\n5.3.1. Erosive Esophagitis Epidemiology Scenario in the 7MM (2019-2032)\n<\/p>\n<p>\n5.4. United States Epidemiology\n<\/p>\n<p>\n5.5. EU-5 Country-wise Epidemiology\n<\/p>\n<p>\n5.5.1. Germany Epidemiology\n<\/p>\n<p>\n5.5.2. France Epidemiology\n<\/p>\n<p>\n5.5.3. Italy Epidemiology\n<\/p>\n<p>\n5.5.4. Spain Epidemiology\n<\/p>\n<p>\n5.5.5. United Kingdom Epidemiology\n<\/p>\n<p>\n5.6. Japan Epidemiology\n<\/p>\n<p>\n<strong>6. Treatment Algorithm, Current Treatment, and Medical Practices<\/strong>\n<\/p>\n<p>\n6.1. Erosive Esophagitis Treatment and Management\n<\/p>\n<p>\n6.2. Erosive Esophagitis Treatment Algorithm\n<\/p>\n<p>\n<strong>7. KOL Views<\/strong>\n<\/p>\n<p>\n<strong>8. Unmet Needs<\/strong>\n<\/p>\n<p>\n<strong>9. Appendix<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5525732\/erosive-esophagitis-epidemiology-forecast-2032?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=k79dxh&amp;utm_campaign=1738125+-+Erosive+Esophagitis+Epidemiology+Forecasts%2C+2032%3A+Focus+on+7MM+-+United+States%2C+Germany%2C+Spain%2C+Italy%2C+France%2C+United+Kingdom%2C+and+Japan&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/ecwsvn<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;&#111;&#x3a;&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#x65;&#115;e&#x61;&#114;c&#x68;&#x61;&#110;d&#x6d;&#97;r&#x6b;&#x65;&#116;s&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#101;s&#x73;&#x40;&#114;e&#x73;&#x65;&#97;rc&#x68;&#97;&#110;d&#x6d;&#x61;&#114;k&#x65;&#x74;&#115;&#46;c&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Erosive Esophagitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47261","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Erosive Esophagitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-12T17:01:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM &#8211; United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-12T17:01:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\"},\"wordCount\":631,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005362\\\/en\\\/1543179\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\",\"name\":\"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005362\\\/en\\\/1543179\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-12T17:01:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005362\\\/en\\\/1543179\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005362\\\/en\\\/1543179\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM &#8211; United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Erosive Esophagitis &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Erosive Esophagitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-12T17:01:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM &#8211; United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com","datePublished":"2022-08-12T17:01:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"wordCount":631,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","name":"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM - United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg","datePublished":"2022-08-12T17:01:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220812005362\/en\/1543179\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/erosive-esophagitis-epidemiology-forecasts-2032-focus-on-7mm-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Erosive Esophagitis Epidemiology Forecasts, 2032: Focus on 7MM &#8211; United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47261"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47261\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}